Adição na publicação
#15.35
10/19/2021
RPI 2650
Back to search
Official data from INPI
COMPOSTO, E, COMPOSIÇÃO FARMACÊUTICA
ArquivadaInvention PatentPCT · EP2018000188
Application data
Number
112019020075Type
Invention Patent
Filing
04/10/2018
Publication
04/28/2020
PCT
EP2018000188 Progress at the INPI
- Filing04/10/18
- Publication04/28/20
- Abandoned
- Allowance
- Grant
- In force
The application was abandoned: examination was not requested within the 36 months following the 04/10/2018 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.
Talk to a specialistLatest action published by the INPI: 10/19/2021. We update with every new RPI gazette, published weekly.
Applicants and inventors
Applicants
PHENEX-FXR GMBH
DE
Inventors
C. G. (pessoa física)
DE
C. K. (pessoa física)
DE
E. H. (pessoa física)
DE
M. B. (pessoa física)
DE
U. D. (pessoa física)
DE
Technical data
IPC Classification
Priority claims
EP
17000610.0 · 04/10/2017
Abstract
A presente invenção refere-se aos compostos contendo sulfonamida, sulfinamida ou sulfonimidamida que se ligam ao receptor X do fígado (LXRa e/ou LXRß) e atuam preferencialmente como agonistas inversos do LXR.
Prosecution history
Publications in the Brazilian Industrial Property Gazette (RPI).
Arquivamento definitivo - Art. 33 da LPI
#11.1.1
10/05/2021
RPI 2648
Arquivamento - Art. 33 da LPI
#11.1
07/20/2021
RPI 2637
Notificação de entrada na fase nacional - PCT
#1.3
04/28/2020
RPI 2573
Alteração de dados cadastrais
#1.1
10/08/2019
RPI 2544
Related
From the same holder
Same category
Patent monitoring
Track this patent in real time.
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.